Somerset Pharmaceutical
Executive Summary
Founder and CEO Albert Buyske, PhD, died Dec. 8 at the age of 64. Prior to founding Somerset, he held executive and scientific positions at Lederle, Ayerst Labs Canada, Warner Lambert, Johnson & Johnson and S.C. Johnson.Buyske was responsible for Somerset's licensing of the anti-Parkinson's drug Eldepryl from the Hungarian government. Somerest was later acquired by generic firms Bolar and Mylan in a joint venture.